Punjab State Biotech Corporation Profile
Key Indicators
- Company Age 13 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -93.14%
(FY 2023)
- Profit -128.75%
(FY 2023)
- Ebitda 46.25%
(FY 2023)
- Net Worth -49.59%
(FY 2023)
- Total Assets -99.44%
(FY 2023)
About Punjab State Biotech Corporation
The Corporate was formerly known as Mohali Biotechnology Park. The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.00 and a paid-up capital of Rs 0.00, as per Ministry of Corporate Affairs (MCA) records.
Jatinder Arora, Ajit Dua, Rahul Tewari, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24239PB2011NPL034638
- Company No.
034638
- Company Classification
Public Not For Profit Company
- Incorporation Date
25 Jan 2011
- Date of AGM
27 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Rupnagar, Punjab, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Punjab State Biotech Corporation?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jatinder Arora  | Director | 25-Jan-2011 | Current |
| Ajit Dua | Nominee Director | 27-Oct-2017 | Current |
| Rahul Tewari | Nominee Director | 19-Apr-2022 | Current |
| Ashwani Pareek | Nominee Director | 01-Jan-2021 | Current |
| Mohit Tewari | Nominee Director | 30-May-2022 | Current |
Financial Performance and Corporate Structure Insights of Punjab State Biotech Corporation.
Punjab State Biotech Corporation, for the financial year ended 2023, experienced significant reduction in revenue, with a 93.14% decrease. The company also saw a substantial fall in profitability, with a 128.75% decrease in profit. The company's net worth observed a substantial decline by a decrease of 49.59%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Punjab State Biotech Corporation?
Unlock access to Punjab State Biotech Corporation's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Punjab State Biotech Corporation?
Unlock and access historical data on people associated with Punjab State Biotech Corporation, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Punjab State Biotech Corporation, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Punjab State Biotech Corporation's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
